Author: Gao, Yong; Qiu, Hai-bo; Zhou, Shu; Wang, Zhen-ning; Zhang, Jian-chu; Zhang, Zheng-liang; Qian, Zhao-xin; Wang, Hong-bo; Yu, Shi-huan; Luo, Yi-feng; Wang, Ya-dan; Liu, Zhuang; Wang, Wei-ci; Jia, Ming; Zhang, Li-ming; Zhang, Yu; Jin, Yang; Zhang, Yong; Liu, Yong; Zhou, Zi-hua; Su, Ying; Li, Hm-qing; Xiao, Wei-min; Huang, Kai; He, Ping; Li, Gang; Fu, Zhao-hui; Liu, Shi; Lin, Neng-xing; Cheng, Fan-jun
Title: Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases Cord-id: zjkq4mpk Document date: 2020_8_7
ID: zjkq4mpk
Snippet: In late December 2019, COVID-19 was firstly recognized in Wuhan, China and spread rapidly to all of the provinces of China. The West Campus of Wuhan Union Hospital, the designated hospital to admit and treat the severe and critically ill COVID-19 cases, has treated a large number of such patients with great success and obtained lots of valuable experiences based on the Chinese guideline (V7.0). To standardize and share the treatment procedures of severe and critically ill cases, Wuhan Union Hosp
Document: In late December 2019, COVID-19 was firstly recognized in Wuhan, China and spread rapidly to all of the provinces of China. The West Campus of Wuhan Union Hospital, the designated hospital to admit and treat the severe and critically ill COVID-19 cases, has treated a large number of such patients with great success and obtained lots of valuable experiences based on the Chinese guideline (V7.0). To standardize and share the treatment procedures of severe and critically ill cases, Wuhan Union Hospital has established a working group and formulated an operational recommendation, including the monitoring, early warning indicators, and several treatment principles for severe and critically ill cases. The treatment experiences may provide some constructive suggestions for treating the severe and critically ill COVID-19 cases all over the world.
Search related documents:
Co phrase search for related documents- abnormal tissue and lung disease: 1
- acid base balance and lopinavir ritonavir: 1, 2, 3
- active infection and lopinavir ritonavir: 1, 2
- active infection and low molecular weight: 1, 2
- active infection and low molecular weight heparin: 1, 2
- active infection and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- lopinavir ritonavir and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- lopinavir ritonavir and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- lopinavir ritonavir and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
- lopinavir ritonavir and lung potential: 1, 2, 3, 4
- lopinavir ritonavir treatment and lung disease: 1
- low molecular weight and lung disease: 1, 2, 3, 4, 5, 6, 7
- low molecular weight heparin and lung disease: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date